Articles

1. Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety

   • Rebecca De Lorenzo
   • Mario G. Mazza
   • Angelo A. Manfredi

   Original Research Article 24 April 2024

   

2. Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data

   • Hasan Çağın Lenk
   • Robert Løvsletten Smith
   • Espen Molden

   Original Research Article Open access 18 April 2024

   

3. Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial

   • Mohamed G. Zeinhom
   • Ahmed Elbassiouny
   • Sherihan Rezk Ahmed

   Original Research Article Open access 15 April 2024 Pages: 387 - 398

   

4. Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management

   • Federico Carbone
   • Atbin Djamshidian

   Current Opinion Open access 13 April 2024

5. Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial

   • Libat Weizman
   • Haggai Sharon
   • Giris Jacob

   Original Research Article Open access 10 April 2024 Pages: 375 - 385

   

6. On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis

   • Fernando L. Pagan
   • Paul E. Schulz
   • Gregory M. Pontone

   Therapy in Practice Open access 08 April 2024 Pages: 333 - 347

   

7. Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review

   • Amira Salim
   • Elise Hennessy
   • Ignacio F. Mata

   Original Research Article Open access 07 April 2024

   

8. CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches

   • Ming Sun
   • Martijn L. Manson
   • Elizabeth C. M. de Lange

   Review Article Open access 05 April 2024 Pages: 349 - 373

   

9. Observation on the Analgesic Effect of Different Doses of a Combination of Esketamine and Dexmedetomidine Administered for Percutaneous Endoscopic Transforaminal Discectomy: A Randomized, Double-Blind Controlled Trial

   • Jian-Shun Zhou
   • Zhen Chen
   • Li-Feng Wang

   Original Research Article 04 April 2024

   

10. The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications

    • Elisa Menozzi
    • Anthony H. V. Schapira

    Leading Article Open access 03 April 2024 Pages: 315 - 331

    

11. The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    • Rachel Goldstein
    • Natalie Rabkin
    • Mordechai Muszkat

    Original Research Article Open access 23 March 2024 Pages: 399 - 408

    

12. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders

    • Nora Vanegas-Arroyave
    • Stanley N. Caroff
    • Samantha A. Cicero

    Current Opinion Open access 19 March 2024 Pages: 239 - 254

    

13. Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period

    • Kathrine Bang Madsen
    • Mette Bliddal
    • Xiaoqin Liu

    Original Research Article Open access 15 March 2024 Pages: 303 - 314

    

14. Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis

    • Rosa Cortese
    • Giovanna Testa
    • Nicola De Stefano

    Review Article Open access 15 March 2024 Pages: 267 - 279

    

15. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options

    • Gemma Mestre-Bach
    • Marc N. Potenza

    Review Article 14 March 2024 Pages: 255 - 265

16. Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis

    • Yue Qiao
    • Jian Gu
    • Ying Ma

    Systematic Review 01 March 2024 Pages: 169 - 192

    

17. The Dose-Response Relationship between Opioid Agonist Therapy and Alterations in Pain Pathways in Patients with Opioid Use Disorders: A Cross-Sectional Study

    • Kordula Lang-Illievich
    • Johanna Lang
    • Helmar Bornemann-Cimenti

    Original Research Article Open access 29 February 2024 Pages: 281 - 290

    

18. Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis

    • Anastasiia D. Shkodina
    • Mainak Bardhan
    • Mykhailo Yu. Delva

    Review Article 29 February 2024 Pages: 205 - 224

    

19. Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study

    • Lucienne Costa-Frossard França
    • Virginia Meca Lallana
    • José Manuel García Domínguez

    Original Research Article Open access 28 February 2024 Pages: 231 - 238

    

20. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

    • Andreas W. Wolff
    • Jörg Peine
    • Paul Lingor

    Original Research Article Open access 28 February 2024 Pages: 291 - 302

    

21. Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data

    • Senta Frol
    • Janja Pretnar Oblak
    • Pawel Kermer

    Current Opinion 23 February 2024 Pages: 163 - 168

22. Unmet Needs in Psychodermatology: A Narrative Review

    • Rachel E. Christensen
    • Mohammad Jafferany

    Review Article 22 February 2024 Pages: 193 - 204

23. Benzodiazepines for the Treatment of Seizure Clusters

    • Patricia E. Penovich
    • Vikram R. Rao
    • Adrian L. Rabinowicz

    Review Article Open access 15 February 2024 Pages: 125 - 140

    

24. Targeting Pannexin-1 Channels: Addressing the ‘Gap’ in Chronic Pain

    • Brendan B. McAllister
    • Sierra Stokes-Heck
    • Tuan Trang

    Leading Article 14 February 2024 Pages: 77 - 91

    

25. The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis

    • Yongbo Ma
    • Xiangtao Nie
    • Xiuming Guo

    Systematic Review 01 February 2024 Pages: 93 - 104

    

26. Trends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study

    • Nofar Benassayag Kaduri
    • Reuven Dressler
    • Victoria Rotshild

    Original Research Article Open access 25 January 2024 Pages: 153 - 162

    

27. Early Experiences with Intrathecal Administration of Amphotericin B Liposomal Formulation at a Neurosurgical Center

    • Michael D. Nailor
    • Kellie J. Goodlet
    • J. Tyler Haller

    Original Research 25 January 2024 Pages: 225 - 229

28. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study

    • Pedro J Serrano-Castro
    • Teresa Ramírez-García
    • Juan De La Parra

    Original Research Article Open access 24 January 2024 Pages: 141 - 151

    

29. Treatment of Sleep, Motor and Sensory Symptoms with the Orexin Antagonist Suvorexant in Adults with Idiopathic Restless Legs Syndrome: A Randomized Double-Blind Crossover Proof-of-Concept Study

    • Diego Garcia-Borreguero
    • Alba Garcia Aragón
    • María Castillo

    Original Research Article 21 January 2024 Pages: 45 - 54

    

30. Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review

    • Sarah Smessaert
    • Johan Detraux
    • Marc De Hert

    Systematic Review 18 January 2024 Pages: 105 - 123

    

31. Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future

    • Salvatore Crisafulli
    • Brigida Boccanegra
    • Annamaria De Luca

    Review Article 11 January 2024 Pages: 15 - 32

    

32. Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia

    • Xin Li
    • Chong Ye
    • Gang Wang

    Original Research Article Open access 08 January 2024 Pages: 55 - 65

    

33. Effect of Levetiracetam on Cognition: A Systematic Review and Meta-analysis of Double-Blind Randomized Placebo-Controlled Trials

    • Chia-Yen Lin
    • Meng-Chia Chang
    • Hong-Jie Jhou

    Systematic Review 15 December 2023 Pages: 1 - 14

    

34. Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia

    • Chuanjun Zhuo
    • Qiuyu Zhang
    • Deguo Jiang

    Review Article Open access 14 December 2023 Pages: 33 - 44

35. Thrombolysis with Recombinant Human Prourokinase 4.5–6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial

    • Haiqing Song
    • Yuan Wang
    • Yuping Wang

    Original Research Article Open access 29 November 2023 Pages: 67 - 75

    

36. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males

    • Markus Goettel
    • Rene Fuertig
    • Johan den Boer

    Original Research Article Open access 29 November 2023 Pages: 1099 - 1109

    

37. Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies

    • René Fuertig
    • Markus Goettel
    • Vikas Sharma

    Original Research Article Open access 29 November 2023 Pages: 1081 - 1097

    

38. Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study

    • Valeria Caponnetto
    • Antonio Russo
    • The Italian Headache Registry (RICe) Study Group

    Original Research Article Open access 24 November 2023 Pages: 1069 - 1080

    

39. Context is a Critical for Psychoactive Drug Effects

    • Kyle T. Greenway

    Commentary 24 November 2023 Pages: 1065 - 1068

40. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review

    • Niloufar Pouyan
    • Farnaz Younesi Sisi
    • Jonathan D. Morrow

    Systematic Review Open access 24 November 2023 Pages: 1027 - 1063

    

41. Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study

    • Mohammed Abou Kaoud
    • Ran Nissan
    • Elad Maor

    Original Research Article 22 November 2023 Pages: 1111 - 1121

    

42. Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany

    • Leonore Purwien
    • Susanne Schubert-Bast
    • Adam Strzelczyk

    Original Research Article Open access 18 November 2023 Pages: 993 - 1008

    

43. Current Insights into Diagnosing and Treating Neurotuberculosis in Adults

    • Sofiati Dian
    • Ahmad Rizal Ganiem
    • Arjan van Laarhoven

    Review Article 17 November 2023 Pages: 957 - 972

    

44. Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    • Laila Aboulatta
    • Lara Haidar
    • Sherif Eltonsy

    Systematic Review 16 November 2023 Pages: 941 - 956

    

45. A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

    • Thomas R. Arkell
    • Brooke Manning
    • Amie C. Hayley

    Original Research Article Open access 09 November 2023 Pages: 981 - 992

    

46. A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy

    • Martin Hirsch
    • Ilka Immisch
    • Andreas Schulze-Bonhage

    Original Research Article Open access 03 November 2023 Pages: 973 - 980

    

47. Acknowledgement to Referees

    Acknowledgement to Referees 30 October 2023 Pages: 1021 - 1026

48. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea

    • Sheridan M. Hoy

    Adis Drug Evaluation 17 October 2023 Pages: 1009 - 1020

49. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials

    • Dania Akbar
    • Taeho Greg Rhee
    • Roger S. McIntyre

    Systematic Review 04 October 2023 Pages: 867 - 881

    

50. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study

    • Yaroslav Winter
    • Katharina Sandner
    • Sergiu Groppa

    Original Research Article Open access 02 October 2023 Pages: 929 - 936